Juventas Cell Therapy Ltd.
PrivateLast Round
Series C
Oct 25, 2021
Est. Valuation
$263.04M
Total Funding Raised
$232.3M
Company Overview
Juventas Cell Therapy Ltd. is a biotechnology company that develops and manufactures innovative immune cell and gene therapies for the treatment of hematological malignancies and other diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Precision Medicine, Drug Discovery
Business Model
B2B
Customer Profile
Data as a Service, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Juventas Cell Therapy Ltd. Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Juventas Cell Therapy Ltd. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Oct 25, 2021 | ||||
| Series C | Jul 12, 2021 | ||||
| Series B | Nov 19, 2020 | ||||
| Series A Extension | Jul 9, 2019 | ||||
| Series A | Dec 17, 2018 |
Key People
Founding team and executive leadership
Juventas Cell Therapy Ltd. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Emerging Technology Partners | Series B |
| CCIC Capital | Series C |
| China International Capital Corporation | Series C |
| Dalton Venture | Series A, Series A Extension |
| Tianjin Venture Capital Management Co., Ltd. | Series C, Series B |
| Oceanpine Capital | Series C |
| Delian Capital | Series C |
Juventas Cell Therapy Ltd. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Juventas Cell Therapy Ltd.'s valuation, stock price, and market status.